The present invention discloses an in vitro method wherein mammalian beta-cell differentiation can be induced in dedifferentiated exocrine pancreatic cells in a medium comprising ligands of the EGF receptor and the GP130 receptor, such as EGF and LIF. Insulin secreting cells, obtainable by this method, provide a means for the treatment of diabetes by islet transplantation.

 
Web www.patentalert.com

< Test strip for a lateral flow assay for a sample containing whole cells

> Genetically altered antibody-producing cell lines with improved antibody characteristics

> Closed photobioreactor system for continued daily in situ production, separation, collection, and removal of ethanol from genetically enhanced photosynthetic organisms
~ 00553